Resection of recurrent ovarian or fallopian tube carcinoma involving the liver

Gynecologic Oncology

Volumn 91, Issue 2, 2003, Pages 383-388

  Yoon, Sam S ^a   Jarnagin, William R ^a   Fong, Yuman ^a   DeMatteo, Ronald P ^a   Barakat, Richard R ^a   Blumgart, Leslie H ^a   Chi, Dennis S ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PACLITAXEL; TOPOTECAN;

ABDOMINAL DISEASE; ADULT; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LIVER LOBECTOMY; LIVER METASTASIS; LIVER RESECTION; LUNG METASTASIS; OVARY CARCINOMA; PELVIC DISEASE; PRIORITY JOURNAL; PROGNOSIS; SPINE DISEASE; TREATMENT OUTCOME; UTERINE TUBE CARCINOMA;

EID: 0242321026     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2003.07.005     Document Type: Conference Paper

References (21)

1. Jemal A., Thomas A., Murray T., Thun M. Cancer statistics, 2002. CA Cancer J Clin. 52:2002;23-47.
2. Ozols R.F., Schwartz P.E., Eifel P.J. Ovarian cancer, fallopian tube carcinoma, and peritoneal carcinoma. DeVita V.T., Hellman S., Rosenberg S.A. Cancer principles and practice of oncology. 2001;1597-1632 Lippincott Williams & Wilkins, Philadelphia.
3. Markman M., Zaino R.J., Fleming P.A., Barakat R.R. Carcinoma of the fallopian tube. Hoskins W.J., Perez C.A., Young R.C. Principles and practice of gynecologic oncology. 3rd ed. 2000;1099-1115 Lippincott Williams & Wilkins, Philadelphia.
4. Armstrong D.K. Relapsed ovarian cancer challenges and management strategies for a chronic disease. Oncologist. 7:(Suppl 5):2002;20-28.
5. Zang R.Y., Zhang Z.Y., Li Z.T., et al. Effect of cytoreductive surgery on survival of patients with recurrent epithelial ovarian cancer. J Surg Oncol. 75:2000;24-30.
6. Vaccarello L., Rubin S.C., Vlamis V., Wong G., et al. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response. Gynecol Oncol. 57:1995;61-65.
7. Tay E.H., Grant P.T., Gebski V., Hacker N.F. Secondary cytoreductive surgery for recurrent epithelial ovarian cancer. Obstet Gynecol. 99:2002;1008-1013.
8. Segna R.A., Dottino P.R., Mandeli J.P., Konsker K., Cohen C.J. Secondary cytoreduction for ovarian cancer following cisplatin therapy. J Clin Oncol. 11:1993;434-439.
9. Scarabelli C., Gallo A., Carbone A. Secondary cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma. Gynecol Oncol. 83:2001;504-512.
10. Janicke F., Holscher M., Kuhn W., et al. Radical surgical procedure improves survival time in patients with recurrent ovarian cancer. Cancer. 70:1992;2129-2136.
11. Gadducci A., Iacconi P., Fanucchi A., Cosio S., Teti G., Genazzani A.R. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer. Anticancer Res. 20:2000;1959-1964.
12. Eisenkop S.M., Friedman R.L., Wang H.J. Secondary cytoreductive surgery for recurrent ovarian cancer. A prospective study. Cancer. 76:1995;1606-1614.
13. Eisenkop S.M., Friedman R.L., Spirtos N.M. The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma. Cancer. 88:2000;144-153.
14. Chi DS, McCaughty K, Schwabenbauer S Identification of prognostic factors for survival following secondary cytoreductive surgery in patients with recurrent epithelial ovarian carcinoma [Abstract]. To be presented at the 34th Annual SGO Meeting; New Orleans, LA.
15. Wolf R.F., Goodnight J.E., Krag D.E., Schneider P.D. Results of resection and proposed guidelines for patient selection in instances of non-colorectal hepatic metastases. Surg Gynecol Obstet. 173:1991;454-460.
16. Harrison L.E., Brennan M.F., Newman E., et al. Hepatic resection for noncolorectal, nonneuroendocrine metastases a fifteen-year experience with ninety-six patients. Surgery. 121:1997;625-632.
17. Chi D.S., Fong Y., Venkatraman E.S., Barakat R.R. Hepatic resection for metastatic gynecologic carcinomas. Gynecol Oncol. 66:1997;45-51.
18. Jarnagin W.R., Gonen M., Fong Y., et al. Improvement in perioperative outcome after hepatic resection analysis of 1,803 consecutive cases over the past decade. Ann Surg. 236:2002;397-406.
19. Dauplat J., Hacker N.F., Nieberg R.K., Berek J.S., Rose T.P., Sagae S. Distant metastases in epithelial ovarian carcinoma. Cancer. 60:1987;1561-1566.
20. Bristow R.E., Montz F.J., Lagasse L.D., Leuchter R.S., Karlan B.Y. Survival impact of cytoreduction in stage IV epithelial ovarian cancer. Gynecol Oncol. 72:1999;278-287.
21. Chi D.S., Temkin S.M., Abu-Rustum N.R., Sabbatini P., Jarnagin W.R., Blumgart L.H. Major hepatectomy at interval debulking for stage IV ovarian carcinoma a case report. Gynecol Oncol. 87:2002;138-142.